The Impact of Pravastatin Pre-Treatment on Periprocedural Microcirculatory Damage in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

The Impact of Pravastatin Pre-Treatment on Periprocedural Microcirculatory Damage in Patients Undergoing Percutaneous Coronary Intervention

Published:2011-05 Issue:5 Volume:4 Page:513-520
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Fujii Kenichi,Kawasaki Daizo,Oka Katsumi,Akahori Hirokuni,Iwasaku Toshihiro,Fukunaga Masashi,Eguchi Akiyo,Sawada Hisashi,Masutani Motomaru,Lee-Kawabata Masaaki,Tsujino Takeshi,Ohyanagi Mitsumasa,Masuyama Tohru

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

3. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial;Serruys;JAMA,2002

4. Myonecrosis after revascularization procedures;Califf;J Am Coll Cardiol,1998

5. for the Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study;Pasceri;Circulation,2004

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microvascular Obstruction in Acute Myocardial Infarction, a Potential Therapeutic Target;Journal of Clinical Medicine;2023-09-13

2. The imPAct of Trimetazidine on MicrOcirculation after Stenting for stable coronary artery disease (PATMOS study);Frontiers in Cardiovascular Medicine;2023-06-30

3. Rapid response to the editor regarding the journal article ‘Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy’;European Heart Journal: Acute Cardiovascular Care;2023-02-28

4. Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial;EuroIntervention;2022-10

5. In search of the pleiotropic effects of PCSK9 inhibitors;EuroIntervention;2022-10